These miRNAs target the extended 3’ UTR regions of several critical activators of the innate immune response–including the IRF5 transcription factor [57] and the MAP kinases MAPKAP1 and MAP2K4 [58]–all of which shift to usage of shorter 3’ UTRs after infection. The gene discussed is IRF5; the disease is infection.